Log in to save to my catalogue

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f96705c65bfd49bc85730e82b064dab7

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

About this item

Full title

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-11, Vol.10 (1), p.5215-14, Article 5215

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Metabolic syndrome is a pathological condition characterized by obesity, hyperglycemia, hypertension, elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol that increase cardiovascular disease risk and type 2 diabetes. Although numerous predisposing genetic risk factors have been identified, the biological mechanis...

Alternative Titles

Full title

A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f96705c65bfd49bc85730e82b064dab7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f96705c65bfd49bc85730e82b064dab7

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-019-13208-z

How to access this item